Citations

Clear

367 citation(s) found for "Su, Pan".

Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy
Jong, Hannah N. De , Dewey, Frederick E., Cordero, Pablo, Victorio, Rachelle A. , Kirillova, Anna , Madhvani, Roshni V., Seo, Kinya , Orcholski, Mark , Liu, W. Robert, Erbilgin, Ayça, Chen, Rui , Pan, Stephen , Bommakanti, Krishna K. , Marcou, Cherisse A. , Bos, J. Martijn , Haddad, François , Ackerman, Michael J. , MacRae, Calum A. , Snyder, M , Parikh, Victoria N. , Ashley, Euan A. , De Jong, Hannah N , Madhvani, Roshni , Seo, Kinya , Werdich, Andreas A , Lan, Feng , Orcholski, Mark , Wheeler, Matthew T , Chen, Rui , Marcou, Cherisse A , Bos, Johan M , Ackerman, Michael J , Vasan, Ramachandran S , MacRae, Calum , Wu, Joseph C , de Jesus Perez, Vinicio , Snyder, Michael , Parikh, Victoria N , Ashley, Euan A , Huang, Yong , Kim, Young M., Vasan, Ramachandran S. , Wu, Joseph C.

Mayo Clinic

Circulation: Genomic and Precision Medicine | June 7, 2022 | Volume: 15 | Issue: 4 | Pages: No page available

10.1161/circgen.121.003563 | PMID 35671065 Get It

Background: The study of hypertrophic cardiomyopathy (HCM) can yield insight into the mechanisms underlying the complex trait of cardiac hypertrophy. To date, most genetic variants associated with HCM have been found in sarcomeric genes. Here, we describe a novel HCM-associated variant in the noncanonical Wnt signaling interactor WTIP (Wilms tumor interacting protein) and provide evidence of a role for WTIP in complex disease. Methods: In a family affected by HCM, we used exome sequencing and identity-by-descent analysis to identify a novel variant in WTIP (p.Y233F). We knocked down WTIP in isolated neonatal rat ventricular myocytes with lentivirally delivered short hairpin ribonucleic acids and in Danio rerio via morpholino injection. We performed weighted gene coexpression network analysis for WTIP in human cardiac tissue, as well as association analysis for WTIP variation and left ventricular hypertrophy. Finally, we generated induced pluripotent stem cell–derived cardiomyocytes from patient tissue, characterized size and calcium cycling, and determined the effect of verapamil treatment on calcium dynamics. Results: WTIP knockdown caused hypertrophy in neonatal rat ventricular myocytes and increased cardiac hypertrophy, peak calcium, and resting calcium in D rerio . Network analysis of human cardiac tissue indicated WTIP as a central coordinator of prohypertrophic networks, while common variation at the WTIP locus was associated with human left ventricular hypertrophy. Patient-derived WTIP p.Y233F-induced pluripotent stem cell–derived cardiomyocytes recapitulated cellular hypertrophy and increased resting calcium, which was ameliorated by verapamil. Conclusions: We demonstrate that a novel genetic variant found in a family with HCM disrupts binding to a known Wnt signaling protein, misregulating cardiomyocyte calcium dynamics. Further, in orthogonal model systems, we show that expression of the gene WTIP is important in complex cardiac hypertrophy phenotypes. These findings, derived from the observation of a rare Mendelian disease variant, uncover a novel disease mechanism with implications across diverse forms of cardiac hypertrophy.
Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
Liao, Tsung-Jen , Pan, Bohu , Hayashi, Paul H. , Ganger, Daniel , Lee, William M. , Rakela, Jorge , Chen, Minjun , Hong, Huixiao , Rule, Jody A.

Mayo Clinic

Clinical and Translational Gastroenterology | June 2, 2022 | Volume: 13 | Issue: 7 | Pages: e00502

10.14309/ctg.0000000000000502 | PMID 35905417 Get It

INTRODUCTION: Indeterminate acute liver failure (IND-ALF) is a rare clinical syndrome with a high mortality rate. Lacking a known etiology makes rapid evaluation and treatment difficult, with liver transplantation often considered as the only therapeutic option. Our aim was to identify genetic variants from whole exome sequencing data that might be associated with IND-ALF clinical outcomes. METHODS: Bioinformatics analysis was performed on whole exome sequencing data for 22 patients with IND-ALF. A 2-tier approach was used to identify significant single-nucleotide polymorphisms (SNPs) associated with IND-ALF clinical outcomes. Tier 1 identified the SNPs with a higher relative risk in the IND-ALF population compared with those identified in control populations. Tier 2 determined the SNPs connected to transplant-free survival and associated with model for end-stage liver disease serum sodium and Acute Liver Failure Study Group prognostic scores. RESULTS: Thirty-one SNPs were found associated with a higher relative risk in the IND-ALF population compared with those in controls, of which 11 belong to the human leukocyte antigen (HLA) class II genes but none for the class I. Further analysis showed that 5 SNPs: rs796202376, rs139189937, and rs113473719 of HLA-DRB5; rs9272712 of HLA-DQA1; and rs747397929 of IDO1 were associated with a higher probability of IND-ALF transplant-free survival. Using 3 selected SNPs, a model for the polygenic risk score was developed to predict IND-ALF prognoses, which are comparable with those by model for end-stage liver disease serum sodium and Acute Liver Failure Study Group prognostic scores. DISCUSSION: Certain gene variants in HLA-DRB5, HLA-DQA1, and IDO1 were found associated with IND-ALF transplant-free survival. Once validated, these identified SNPs may help elucidate the mechanism of IND-ALF and assist in its diagnosis and management.
Cytokeratin-Derived Amyloid Mimicking Invasive Squamous Cell Carcinoma: Overcoming a Potential Pitfall of Pan-Cytokeratin Immunohistochemistry–Assisted Mohs Micrographic Surgery
Idriss, Munir H., Ahn, Ji Won, Johnson, Emma F. , Vidal, Nahid Y. , Demer, Addison M.

Mayo Clinic

Dermatologic Surgery | May 26, 2022 | Volume: 48 | Issue: 8 | Pages: 887-889

10.1097/dss.0000000000003493 | PMID 35617106 Get It

Impact of β-blockers on Survival Outcomes in Patients with Unresectable Hepatocellular Carcinoma
Altshuler, Ellery , Kallumkal, Govind, Gao, Hanzhi, Wilson, Jake, Ouni, A. El , Leo, Edward De , Hanayneh, Wissam , Pan, Kelsey , Ouni, Ahmed, Aryan, Mahmoud , Ouni, Ahmed

Mayo Clinic

Hepatic Oncology | May 24, 2022 | Volume: 9 | Issue: 2 | Pages: No page available

10.2217/hep-2021-0010 | PMID 35665305 Get It

Selecting venues for AMIA events and conferences: guiding ethical principles
Lehmann, Christoph U. , Hollis, Kate Fultz , Petersen, Carolyn , DeMuro, Paul R. , Subbian, Vignesh , Koppel, Ross , Solomonides, Anthony , Pan, Eric, Fultz Hollis, Kate , Solomonides, Anthony E , Pan, Eric C , Goodman, Kenneth W , Koppel, Ross , Lehmann, Christoph U , Petersen, Carolyn , Subbian, Vignesh , Berner, Eta S. , Adler‐Milstein, Julia , Goodman, Kenneth W.

Mayo Clinic

Journal of the American Medical Informatics Association | April 28, 2022 | Volume: 29 | Issue: 8 | Pages: 1319-1322

10.1093/jamia/ocac073 | PMID 35579334 Get It

Abstract A discussion and debate on the American Medical Informatics Association’s (AMIA) Ethical, Legal, and Social Issues (ELSI) Working Group listserv in 2021 raised important issues related to a forthcoming conference in Texas. Texas had recently enacted a restrictive abortion law and restricted voting rights. Several AMIA members advocated for a boycott of the state and the scheduled conference. The discussion led the AMIA Board of Directors to request that the organization’s Ethics Committee provide general guidance for principle-based venue selection. This document recommends overarching principles for the venue selection for future AMIA events and conferences. Discussions by the AMIA Board, the Ethics Committee, and the ELSI Working Group informed these recommendations, and this document on guiding principles was approved by the AMIA Board of Directors in April 2022.
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials
Chen, Jui‐Yi , Pan, Heng‐Chih , Hsieh, Chih-Chieh , Hsu, Tsuen‐Wei , Huang, Yun‐Ting , Huang, Tao‐Min , Huang, Chun-Te , Chen, Yung‐Ming , Shiao, Chih‐Chung , Kashani, Kianoush , Wu, Vin‐Cent

Mayo Clinic

Clinical Kidney Journal | March 29, 2022 | Volume: 15 | Issue: 5 | Pages: 1027-1027

10.1093/ckj/sfac059 | PMID 35503545 Get It

Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia
Pettigrew, Melinda M. , Kwon, Jiye , Gent, Janneane F., Kong, Yong , Wade, Martina , Creech, C. Buddy , Pan, Qing , Walter, Emmanuel B. , Martin, Judith M. , Gerber, Jeffrey S. , Newland, Jason G. , Hofto, Meghan E. , Staat, Mary Allen , Fowler, Vance G. , Chambers, Henry F. , Pettigrew, M M , Martin, J M , Staat, Mary A , Williams, Derek J. , Evans, Scott , Fowler, Vance G. , Huskins, W. Charles

Mayo Clinic

mBio | March 24, 2022 | Volume: 13 | Issue: 2 | Pages: No page available

10.1128/mbio.00195-22 | PMID 35323040 Get It

Antibiotic resistance is a major threat to public health. Treatment strategies involving shorter antibiotic courses have been proposed as a strategy to lower the potential for antibiotic resistance.
Abstract P281: Urinary Metabolites Associated With Blood Pressure on a Low- or High-sodium Diet
Xue, Hong , Song, Haiying , Wan, Yifei, Wang, Tao , Liu, Pengyuan , Liu, Yong , Laud, Purushottam W. , Usa, Kristie , He, Yongcheng , Xue, Hong, Cheng, Yuan , Pan, Xiaoqing, Tian, Zhongmin , Hou, Entai , Lanza, Ian R. , Liang, Mingyu

Mayo Clinic

Hypertension | March 20, 2022 | Volume: 70 | Issue: suppl_1 | Pages: No page available

10.1161/hyp.70.suppl_1.p281 Get It

Dietary salt intake has significant effects on arterial blood pressure and the development of hypertension. Mechanisms underlying salt-dependent changes in blood pressure remain poorly understood. The goal of the present study was to utilize urine samples from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial and a targeted metabolomic approach to identify associations of urinary metabolites with blood pressure phenotypes on low- or high-sodium intake. We examined urinary levels of metabolites in 103 participants of the DASH-Sodium trial after 30 days on a defined diet containing high sodium (targeting 150 mmol sodium intake per day) or low sodium (50 mmol sodium per day). Systolic or diastolic pressure was 10 or more mmHg higher on the high-sodium intake in 51 of the 103 participants. Targeted chromatography/mass spectrometry analysis was performed in 24-h urine samples for 10 metabolites related to the tricarboxylic acid cycle and 47 amino metabolites. Urinary metabolite levels improved the prediction of classification of blood pressure salt-sensitivity based on race, age and sex. Random forest and generalized linear mixed model analyses identified significant (false discovery rate <0.05) associations between 24 h excretions of β-aminoisobutyric acid, cystine, citrulline, homocysteine and lysine and systolic blood pressure and between cystine and diastolic blood pressure. The differences of 24 h excretion of homocysteine between low- and high-sodium intakes were significantly associated with the differences in diastolic blood pressure. These associations were significant with or without considering demographic factors. Treatment with β-aminoisobutyric acid significantly attenuated high-salt-induced hypertension in Dahl salt-sensitive rats. These findings support the presence of new mechanisms of blood pressure regulation involving metabolic intermediaries.
Abstract 10303: CRRL290: A Novel and Mechanism-Based Therapeutic Peptide Targeting the Crosstalk Between Angiotensin II and the Natriuretic Peptide System for Cardiorenal Disease
Reginauld, Shawn, Pan, Shuchong, Ye, Zheng , Cannone, Valentina , Sangaralingham, Jeson, Burnett, John C. , Ma, Xiao , Iyer, Seethalakshmi

Mayo Clinic

Circulation | March 19, 2022 | Volume: 144 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.144.suppl_1.10303 Get It

Introduction: Therapeutic strategies dual-targeting renin-angiotensin system (RAS) and natriuretic peptide system (NPS), such as Sacubitril/Valsartan, have been proven promising in treating cardiorenal disease (CRD). However, mechanisms behind the crosstalk between RAS and NPS remain to be fully elucidated. While angiotensin II (ANGII), the central RAS hormone, is thought to interact with NPS at multiple levels, whether and how it may influence the actions of particulate guanylyl cyclase A (pGC-A), the receptor activated by ANP and BNP to increase its second messenger cGMP, has not been investigated. Hypothesis: We hypothesize ANGII naturally suppresses pGC-A activity and inhibition of this ANGII mediated action can be a new strategy to combat CRD. Methods: Studies consist of biomarker analyses in plasma from healthy humans, drug infusions in normal rats, molecular characterization in human HEK293 cells, and in vitro assessment of CRRL290, an innovative dual-functional peptide designed to activate pGC-A and inhibit protein kinase C (PKC). Results: In 128 healthy humans, plasma cGMP was positively associated with ANP or BNP in low (≤ 4.5 pg/mL) but not those with high (> 4.5 pg/mL) ANGII levels. Infusion of ANP (300 pmol/kg/min) in normal rats increased plasma and urinary cGMP, however ANP mediated cGMP generation was reduced in the presence of ANGII. Interestingly, suppression effect of ANGII on pGC-A was only recapitulated in HEK293 cell overexpressing both pGC-A and AT1R, but not in HEK293 cell overexpressing pGC-A alone. We also found PKC, a known downstream target of AT1R, was a key mediator as the suppression effect of ANGII was largely ablated by Go6983, a pan PKC inhibitor. Accordingly, we designed and synthesized CRRL290. Notably, CRRL290 had superior potency in cGMP generation compared to the currently best-in-class ANP-analog, MANP, in HEK293 cells. Conclusions: We demonstrate that ANGII is a natural suppressor of pGC-A via AT1R and PKC signaling. We also report for the first time that CRRL290, a novel bioengineered peptide that activates pGC-A receptor while inhibiting PKC signaling, potently generates cGMP. Our study provides new insights into the RAS-NPS interaction, and highlights a novel and mechanism-based therapeutic avenue for treating CRD.
Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk
Shu, Xiao-Ou , Chen, Zhishan, Long, Jirong, Guo, Xingyi, Yang, Yaohua , Qu, Conghui, Ahn, Yoon-Ok, Cai, Qiuyin , Casey, Graham, Gruber, Stephen B. , Huyghe, Jeroen R. , Jee, Sun Ha, Jenkins, Mark A., Jia, Wei-Hua, Jung, Keum Ji, Kamatani, Yoichiro, Kim, Dong-Hyun, Marchand, Loic Le, Newcomb, Polly A., Oh, Jae Hwan, Ose, Jennifer , Pai, Rish K. , Pan, Zhi-Zhong, Ren, Ze-Fang, Shin, Aesun, Sun, Xiaohui, Tangen, Catherine M., Tanikawa, Chizu, Duijnhoven, Fränzel J.B. van , Guelpen, Bethany Van , Woods, Michael O. , Wu, Anna H., Peters, Ulrike , Jee, Sun Ha , Chen, Zhishan , Shu, Xiao-Ou , Kim, Jeongseon , Kweon, Sun-Seog , Matsuda, Koichi , Matsuo, Keitaro , Ose, Jennifer , Oze, Isao , Pai, R K , Pharoah, Paul D P , Playdon, Mary C , Schoen, Robert E , Shin, Min‐Ho , Shu, Xiao-Ou , Ulrich, Cornelia M , van Duijnhoven, Fränzel J B , Van Guelpen, Bethany , Wolk, Alicja , Woods, Michael O , Peters, Ulrike , Zheng, Wei , Gruber, Stephen B , Cai, Qiuyin , Chen, Zhishan, Long, Jirong, Guo, Xingyi, Yang, Yaohua , Qu, Conghui, Ahn, Yoon-Ok, Casey, Graham, Huyghe, Jeroen R , Jenkins, Mark A., Jia, Wei-Hua, Jung, Keum Ji, Kamatani, Yoichiro, Kim, Dong-Hyun, Marchand, Loic Le, Newcomb, Polly A., Oh, Jae Hwan, Pan, Zhi-Zhong, Ren, Ze-Fang, Shin, Aesun, Sun, Xiaohui, Tangen, Catherine M., Tanikawa, Chizu, Wu, Anna H.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 10, 2022 | Volume: 31 | Issue: 6 | Pages: 1216-1226

10.1158/1055-9965.epi-21-1008 | PMID 35266989 Get It

Abstract Background: The etiology of colorectal cancer is not fully understood. Methods: Using genetic variants and metabolomics data including 217 metabolites from the Framingham Heart Study (n = 1,357), we built genetic prediction models for circulating metabolites. Models with prediction R2 &gt; 0.01 (Nmetabolite = 58) were applied to predict levels of metabolites in two large consortia with a combined sample size of approximately 46,300 cases and 59,200 controls of European and approximately 21,700 cases and 47,400 controls of East Asian (EA) descent. Genetically predicted levels of metabolites were evaluated for their associations with colorectal cancer risk in logistic regressions within each racial group, after which the results were combined by meta-analysis. Results: Of the 58 metabolites tested, 24 metabolites were significantly associated with colorectal cancer risk [Benjamini–Hochberg FDR (BH-FDR) &lt; 0.05] in the European population (ORs ranged from 0.91 to 1.06; P values ranged from 0.02 to 6.4 × 10−8). Twenty one of the 24 associations were replicated in the EA population (ORs ranged from 0.26 to 1.69, BH-FDR &lt; 0.05). In addition, the genetically predicted levels of C16:0 cholesteryl ester was significantly associated with colorectal cancer risk in the EA population only (OREA: 1.94, 95% CI, 1.60−2.36, P = 2.6 × 10−11; OREUR: 1.01, 95% CI, 0.99−1.04, P = 0.3). Nineteen of the 25 metabolites were glycerophospholipids and triacylglycerols (TAG). Eighteen associations exhibited significant heterogeneity between the two racial groups (PEUR-EA-Het &lt; 0.005), which were more strongly associated in the EA population. This integrative study suggested a potential role of lipids, especially certain glycerophospholipids and TAGs, in the etiology of colorectal cancer. Conclusions: This study identified potential novel risk biomarkers for colorectal cancer by integrating genetics and circulating metabolomics data. Impact: The identified metabolites could be developed into new tools for risk assessment of colorectal cancer in both European and EA populations.